Organovo Holdings, Inc. (NASDAQ:ONVO) released its earnings results on Wednesday. The company reported ($0.10) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.10), Briefing.com reports. Organovo Holdings had a negative net margin of 918.97% and a negative return on equity of 64.25%. The firm had revenue of $0.99 million during the quarter, compared to the consensus estimate of $0.92 million. Organovo Holdings’s quarterly revenue was up 11.1% compared to the same quarter last year.

Organovo Holdings (NASDAQ ONVO) traded up 1.45% on Friday, reaching $2.10. 1,142,613 shares of the company traded hands. The stock’s 50-day moving average is $2.46 and its 200-day moving average is $2.86. Organovo Holdings has a 1-year low of $2.00 and a 1-year high of $4.66.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/organovo-holdings-inc-nasdaqonvo-releases-earnings-results-hits-estimates/1476036.html.

A number of hedge funds have recently made changes to their positions in the stock. ARK Investment Management LLC raised its stake in shares of Organovo Holdings by 134.5% in the second quarter. ARK Investment Management LLC now owns 1,445,039 shares of the company’s stock valued at $3,800,000 after buying an additional 828,787 shares during the period. Vanguard Group Inc. raised its stake in shares of Organovo Holdings by 8.5% in the first quarter. Vanguard Group Inc. now owns 4,250,017 shares of the company’s stock valued at $13,515,000 after buying an additional 333,034 shares during the period. Meridian Wealth Management LLC acquired a new stake in shares of Organovo Holdings during the first quarter valued at about $321,000. UBS Group AG raised its stake in shares of Organovo Holdings by 31.3% in the first quarter. UBS Group AG now owns 1,289,100 shares of the company’s stock valued at $4,099,000 after buying an additional 306,982 shares during the period. Finally, Norges Bank acquired a new stake in shares of Organovo Holdings during the fourth quarter valued at about $1,030,000. Institutional investors own 22.77% of the company’s stock.

A number of research analysts have recently weighed in on the stock. BidaskClub downgraded shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 25th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $4.00 price objective on shares of Organovo Holdings in a report on Thursday, July 27th. Finally, Evercore ISI reaffirmed an “outperform” rating and issued a $3.75 price objective (down from $4.00) on shares of Organovo Holdings in a report on Friday, June 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. Organovo Holdings has a consensus rating of “Buy” and an average price target of $6.20.

Organovo Holdings Company Profile

Earnings History for Organovo Holdings (NASDAQ:ONVO)

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.